Seroatlas · Human Serome Atlas

MEF2D

Myocyte-specific enhancer factor 2D

Also known as: MEF2D_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q14814
Gene
MEF2D
Ensembl
ENSG00000116604
Chromosome
1
Canonical length
521 aa
Protein class
Predicted intracellular proteins, Transcription factors
Subcellular location
Nucleoplasm,Vesicles

OverviewNCBI Gene

This gene is a member of the myocyte-specific enhancer factor 2 (MEF2) family of transcription factors. Members of this family are involved in control of muscle and neuronal cell differentiation and development, and are regulated by class II histone deacetylases. Fusions of the encoded protein with Deleted in Azoospermia-Associated Protein 1 (DAZAP1) due to a translocation have been found in an acute lymphoblastic leukemia cell line, suggesting a role in leukemogenesis. The encoded protein may also be involved in Parkinson disease and myotonic dystrophy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012]

Canonical amino-acid sequenceUniProt

521 residues, UniProt reviewed canonical sequence.

>Q14814|MEF2D
     1  MGRKKIQIQR ITDERNRQVT FTKRKFGLMK KAYELSVLCD CEIALIIFNH SNKLFQYAST
    61  DMDKVLLKYT EYNEPHESRT NADIIETLRK KGFNGCDSPE PDGEDSLEQS PLLEDKYRRA
   121  SEELDGLFRR YGSTVPAPNF AMPVTVPVSN QSSLQFSNPS GSLVTPSLVT SSLTDPRLLS
   181  PQQPALQRNS VSPGLPQRPA SAGAMLGGDL NSANGACPSP VGNGYVSARA SPGLLPVANG
   241  NSLNKVIPAK SPPPPTHSTQ LGAPSRKPDL RVITSQAGKG LMHHLTEDHL DLNNAQRLGV
   301  SQSTHSLTTP VVSVATPSLL SQGLPFSSMP TAYNTDYQLT SAELSSLPAF SSPGGLSLGN
   361  VTAWQQPQQP QQPQQPQPPQ QQPPQPQQPQ PQQPQQPQQP PQQQSHLVPV SLSNLIPGSP
   421  LPHVGAALTV TTHPHISIKS EPVSPSRERS PAPPPPAVFP AARPEPGDGL SSPAGGSYET
   481  GDRDDGRGDF GPTLGLLRPA PEPEAEGSAV KRMRLDTWTL K

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against MEF2D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.69
Highest tissue expression
158 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 158 nTPM
  • blood vessel: 92 nTPM
  • bone marrow: 75 nTPM
  • tongue: 65 nTPM
  • heart muscle: 51 nTPM
  • retina: 46 nTPM

Single-cell type

  • neutrophils: 259 nCPM
  • cone photoreceptor cells: 217 nCPM
  • pdcs: 159 nCPM
  • rod photoreceptor cells: 130 nCPM
  • myonuclei: 127 nCPM
  • vascular smooth muscle cells: 127 nCPM

Immune cell

  • plasmacytoid DC: 5.5 nTPM
  • neutrophil: 5.1 nTPM
  • eosinophil: 1.5 nTPM
  • MAIT T-cell: 1.4 nTPM
  • non-classical monocyte: 1.4 nTPM
  • classical monocyte: 1.3 nTPM

Brain region

  • cerebral cortex: 113 nTPM
  • cerebellum: 108 nTPM
  • hippocampal formation: 106 nTPM
  • basal ganglia: 105 nTPM
  • amygdala: 96 nTPM
  • white matter: 91 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.24
gnomAD pLI
1
gnomAD missense Z
2.25
DepMap mean gene effect
-0.13
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of MEF2D in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads MEF2D as an antibody target. Whether an autoantibody or antibody against MEF2D could matter depends on whether native MEF2D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

MEF2D is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label MEF2D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/MEF2D. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...